View more job listings or post a job
Genentech Associate Scientist(Contract)
AbVision Inc. Cellular and Molecular Immunologist (all levels available; Job Code: 122718CC )
Master of Biotechnology- SJSU Now accepting applications for the Fall 2019 cohort! Apply now! Deadline April 1, 2019 Contact for information: Dr. Sabine Rech or Dr. Leila Khatib
Hangzhou Zenshine Pharmaceuticals Director/Senior Director, Oncology
Genentech Scientific Researcher / Senior Scientific Researcher, Drug Metabolism And Pharmacokinetics
Hughes and Associates Senior Scientist Large Molecule Bioanalysis
Hughes and Associates Associate Director DMPK
Hughes and Associates Associate Director, Clinical Pharmacology and Pharmacometrics
Hughes and Associates Senior Director Clinical Pharmacology
Post a job


Promising Therapeutic Approaches and Translational Medicine to Advance Novel Therapeutics (A Joint Symposium by PBSS and Stanford SPARK Program)

Organizers: Kevin Grimes (Stanford), Shichang Miao (ChemoCentryx), Snow Ge (Nektar), Greg Wagner
Date: 3/7/2019
Time: 8:45-17:00
Registration fee (USD): Regular: $100; Academic: $50; Students/Postdocs & Unemployed: $20;
Location: Crowne Plaza, Foster City, CA
Major Sponsor:
Vendor show vendors registered to date: (2)Applied StemCell; Medpace
Registration deadline:3/7/2019  (it will close sooner if the seating cap is reached)

About the Topic

This joint symposium between PBSS and the Stanford SPARK translational research program will review how industry and academia can work together to successfully translate academic research into commercial opportunities and will present examples of current and past SPARK projects. 

Academics often make promising discoveries that could lead to novel therapeutics, but lack the expertise to advance their science to a stage here commercial partners would be interested. The Stanford SPARK program is a collaboration between academic scientists and individuals from the local biopharmaceutical community who are willing to share their knowledge and expertise. SPARK is now in its twelfth year and nearly 50% of projects completing the program have been transferred to commercial partners. An additional 10% have entered investigator-initiated clinical trials. 

The following topics will be covered:

  • Introduction to the Stanford SPARK Translational Research Program and Overview of Drug Discovery in the Academic Setting (Kevin Grimes, Professor, Co-Director of SPARK, Stanford)
  • Peptide therapeutics for heart failure (or for Huntington's disease) (Daria Mochly-Rosen, Professor, Co-Director of SPARK, Stanford)
  • myc animal models and two therapeutic projects (Dean Felsher, Professor, Stanford)
  • New treatment for dementia (Mehrdad Shamloo, Professor, Stanford)
  • Antivirals targeting the host  (Shirit Einav, Professor, Stanford)
  • Genomically-modfied cell therapies for IPEX syndrome (Rosa Bacchetta, Professor, Stanford)
  • Drug target overview and selection: from the industry perspective (speaker TBD)
  • Clinical candidate selection (John Link, VP  Medchem, Gilead) 
  • Funding for startupsseed/angel/VC funding and non-dilutive funding such as SBIR (Keith Wycoff, VP Research, Planet Biotechnology)
  • GMP overview for small and/or large molecules (speaker TBD)
  • IP considerations when starting a company: Avoid the Pitfalls and Set for Success (Janet Xiao, Partner, Morrison Foerster)


2019-02-07, Covalent Inhibitor Drug Discovery & Development: Biology, Chemistry, PK, Safety and Case Studies (Jointly with Bay Area PKPD Network)
2019-03-11, Clinical Trials Essentials: An Intensive One-Week Course (register for the full week or half day sessions)
2019-04-25, Save the Date: Tox-21 (jointly by SOT-NorCal & PBSS)
2019-05-06, CMC Development for Biologics
┬ęPharmaceutical & BioScience Society, International; Last Modified: 1/24/2019; Visited: 1236; Admin Logon
Ads (in random order)
Submit a Text Ad
($200 for 2 months)